Alligator Bioscience AB(SE:ATORX)
kr 0.010.00 (0.00%)
SE:ATORX
Alligator Bioscience AB financials statements
kr 0.01
At close:0.00 (0.00%)
Want to see SE:ATORX full AI Analyst Report?
Alligator Bioscience AB (ATORX) Ratios
4 Followers
Alligator Bioscience AB Ratios
SE:ATORX's free cash flow for Q3 2026 was kr-18.68M. For the 2026 fiscal year, SE:ATORX's free cash flow was increased by kr0.00 and operating cash flow was kr-18.68M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.88 | 0.35 | 0.79 | 1.90 | 6.32 |
| Quick Ratio | 0.88 | 0.35 | 0.79 | 1.90 | 6.32 |
| Cash Ratio | 0.80 | 0.32 | 0.67 | 1.51 | 5.87 |
| Solvency Ratio | -0.59 | -0.79 | -2.23 | -2.26 | -2.56 |
| Operating Cash Flow Ratio | -2.00 | -1.05 | -1.91 | -2.67 | -2.68 |
| Short-Term Operating Cash Flow Coverage | -18.69 | 0.00 | 0.00 | 0.00 | 19.38 |
| Net Current Asset Value | kr -35.08M | kr -163.53M | kr -28.41M | kr 42.28M | kr 248.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.42 | 0.14 | 0.14 | 0.03 |
| Debt-to-Equity Ratio | 6.29 | -0.33 | 1.36 | 0.28 | 0.03 |
| Debt-to-Capital Ratio | 0.86 | -0.50 | 0.58 | 0.22 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 16.13 | -0.80 | 9.99 | 1.90 | 1.18 |
| Debt Service Coverage Ratio | -2.32 | -8.40 | -491.95 | -280.16 | 20.64 |
| Interest Coverage Ratio | -2.76 | -11.64 | -515.49 | -298.43 | -612.84 |
| Debt to Market Cap | 3.66 | 0.00 | 0.00 | 0.00 | -0.00 |
| Interest Debt Per Share | 3.18 | 7.28 | 3.13 | 3.81 | 1.51 |
| Net Debt to EBITDA | 0.16 | 0.13 | 0.21 | 0.40 | 2.06 |
| Profitability Margins | |||||
| Gross Profit Margin | -10665.18% | 100.00% | 100.00% | -313.84% | -572.04% |
| EBIT Margin | -21738.13% | -370.80% | -426.98% | -540.00% | -1093.29% |
| EBITDA Margin | -23731.71% | -286.45% | -408.92% | -507.03% | -1007.42% |
| Operating Profit Margin | -23780.54% | -396.66% | -428.49% | -540.09% | -1093.76% |
| Pretax Profit Margin | -9990.27% | -404.89% | -427.81% | -541.81% | -1095.07% |
| Net Profit Margin | -9990.27% | -404.89% | -427.81% | -541.79% | -1095.07% |
| Continuous Operations Profit Margin | -9990.27% | -404.89% | -427.81% | -541.81% | -1095.07% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 42.01% | 102.07% | 99.84% | 100.32% | 100.12% |
| Return on Assets (ROA) | -46.43% | -224.17% | -209.87% | -114.04% | -42.54% |
| Return on Equity (ROE) | -748.65% | 179.11% | -2096.89% | -217.18% | -50.21% |
| Return on Capital Employed (ROCE) | -376.59% | 235.95% | -1285.34% | -183.51% | -49.54% |
| Return on Invested Capital (ROIC) | -244.42% | 263.33% | -890.75% | -169.77% | -49.59% |
| Return on Tangible Assets | -72.80% | -305.85% | -247.38% | -127.60% | -44.99% |
| Earnings Yield | -553.71% | -10.82% | -6.80% | -1.89% | -0.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.08 | 79.57 | 29053.50 | 1.96 | 0.89 |
| Payables Turnover | 12.09 | 23.88 | 0.00 | 11.07 | 9.29 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.27 | 19.12 | 2.86 | 1.33 | 0.84 |
| Asset Turnover | 0.00 | 0.55 | 0.49 | 0.21 | 0.04 |
| Working Capital Turnover Ratio | -0.01 | -0.77 | 3.11 | 0.23 | 0.08 |
| Cash Conversion Cycle | 4560.02 | -10.69 | 0.01 | 153.09 | 369.32 |
| Days of Sales Outstanding | 4590.19 | 4.59 | 0.01 | 186.06 | 408.63 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 30.18 | 15.28 | 0.00 | 32.97 | 39.31 |
| Operating Cycle | 4590.19 | 4.59 | 0.01 | 186.06 | 408.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.67 | -24.46 | -35.68 | -26.18 | -19.23 |
| Free Cash Flow Per Share | -5.72 | -24.46 | -36.15 | -26.25 | -19.24 |
| Dividend Paid and CapEx Coverage Ratio | -106.77 | 0.00 | -76.98 | -392.29 | -2822.96 |
| Capital Expenditure Coverage Ratio | -106.77 | 0.00 | -76.98 | -392.29 | -2822.96 |
| Operating Cash Flow Coverage Ratio | -3.61 | -4.88 | -11.76 | -7.04 | -13.05 |
| Operating Cash Flow to Sales Ratio | -303.47 | -3.68 | -3.26 | -4.84 | -9.81 |
| Free Cash Flow Yield | -1697.75% | -9.82% | -5.25% | -1.69% | -0.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.18 | -9.25 | -14.70 | -52.84 | -119.78 |
| Price-to-Sales (P/S) Ratio | 18.04 | 37.43 | 62.90 | 286.30 | 1311.71 |
| Price-to-Book (P/B) Ratio | 1.35 | -16.56 | 308.29 | 114.76 | 60.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.06 | -10.18 | -19.06 | -59.06 | -133.60 |
| Price-to-Operating Cash Flow Ratio | -0.06 | -10.18 | -19.31 | -59.21 | -133.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.22 | -0.00 | 1.32 | 4.46 |
| Enterprise Value Multiple | 0.08 | -12.94 | -15.17 | -56.06 | -128.15 |
| Enterprise Value | -9.77M | 2.14B | 3.60B | 10.15B | 16.71B |
| EV to EBITDA | 0.08 | -12.94 | -15.17 | -56.06 | -128.15 |
| EV to Sales | -19.01 | 37.07 | 62.04 | 284.26 | 1290.97 |
| EV to Free Cash Flow | 0.06 | -10.08 | -18.80 | -58.64 | -131.49 |
| EV to Operating Cash Flow | 0.06 | -10.08 | -19.04 | -58.79 | -131.53 |
| Tangible Book Value Per Share | -1.21 | -18.25 | -1.15 | 10.77 | 39.98 |
| Shareholders’ Equity Per Share | 0.25 | -15.04 | 2.23 | 13.51 | 42.73 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.02 | 6.65 | 10.95 | 5.41 | 1.96 |
| Net Income Per Share | -1.87 | -26.93 | -46.86 | -29.33 | -21.46 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.46 | 1.09 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 181.89 | 2.65 | 3.50 | 3.78 | 8.51 |
| SG&A to Revenue | -50.74 | -0.90 | 0.00 | 0.00 | 1.46 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.04 | 0.93 | 0.76 | 0.90 | 0.90 |
Currency in SEK
